1. 20/#1057 Integrated profiling of a prospective endometrial cancer organoid biobank reveals high heterogeneity. (4th December 2022) Authors: Berg, Hege; Hjelmeland, Marta; Lien, Hilde; Espedal, Heidi; Pal, Sangita; Srivastava, Aashish; Stokowy, Tomasz; Stefansson, Ingunn; Bjørge, Line; Hoivik, Erling; Haldorsen, Ingfrid; Beroukhim, Rameen; Krakstad, Camilla Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-RA-1383-ESGO High visceral fat percentage is linked to upregulated inflammatory tumour signalling and predicts poor outcome in uterine cervical cancer. (20th October 2022) Authors: Eide, Agnes Jørgensen; Halle, Mari Kyllesø; Lura, Njål; Fasmer, Kristine; Wagner-Larsen, Kari; Forsse, David Erik; Bertelsen, Bjørn; Salvesen, Øyvind; Krakstad, Camilla; Haldorsen, Ingfrid Salvesen Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2022-RA-1476-ESGO Targeting androgen and estrogen receptor signaling in patient-derived endometrial cancer organoids. (20th October 2022) Authors: Hjelmeland, Marta Espevold; Berg, Hege; Kurnit, Katherine; Woie, Kathrine; Srivastava, Aashish; Stokowy, Tomasz; Fleming, Gini; Szmulewitz, Russell; Krakstad, Camilla Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2022-RA-799-ESGO Impact of imaging- and pathology findings for stage migration and prognostication using the FIGO (2018) staging system in cervical cancer. (20th October 2022) Authors: Wagner-Larsen, Kari Strøno; Lura, Njål; Halle, Mari Kyllesø; Salvesen, Øyvind; Bertelsen, Bjørn Inge; Woie, Kathrine; Krakstad, Camilla; Haldorsen, Ingfrid Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 2022-RA-803-ESGO Functional characterization of nrip1 in endometrial cancer; mutations associates with aggressive features while low expression levels predict poor survival. (20th October 2022) Authors: Bredin, Hanna Kosberg; Bjune, Jan-Inge; Berg, Hege; Halle, Mari Kyllestø; Mellgren, Gunnar; Trovik, Jone; Krakstad, Camilla; Hoivik, Erling Andre Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A407 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 2022-RA-905-ESGO Mismatch repair deficiency is not applicable as biomarker in cervical cancer, yet MSH-2 has strong prognostic value. (20th October 2022) Authors: van den Berg, Madeleine Charlotte; Berg, Hege Fredriksen; Stokowy, Thomas; Hoivik, Erling; Woie, Kathrine; Engerud, Hilde; Ojesina, Akinyemi I; Salvesen Haldorsen, Ingfrid Helene; Bertelsen, Bjørn Inge; Trovik, Jone; Halle, Mari Kyllesø; Krakstad, Camilla Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 2022-RA-911-ESGO 18F-FDG-PET/CT in orthotopic mouse models of endometrial cancer: multiparametric characterization and evaluation of treatment response. (20th October 2022) Authors: Lyngstad, Jenny; Berg, Hege Fredriksen; Fonnes, Tina; Krakstad, Camilla; Haldorsen, Ingfrid Salvesen; Espedal, Heidi Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Annexin‐A2 as predictor biomarker of recurrent disease in endometrial cancer. Issue 8 (29th September 2014) Authors: Alonso‐Alconada, Lorena; Santacana, Maria; Garcia‐Sanz, Pablo; Muinelo‐Romay, Laura; Colas, Eva; Mirantes, Cristina; Monge, Marta; Cueva, Juan; Oliva, Esther; Soslow, Robert A; Lopez, Maria Angeles; Palacios, Jose; Prat, Jaime; Valls, Joan; Krakstad, Camilla; Salvesen, Helga; Gil‐Moreno, Antonio;... Journal: International journal of cancer Issue: Volume 136:Issue 8(2015:Apr. 15) Page Start: 1863 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. APOBEC3A/B deletion polymorphism and endometrial cancer risk. (16th November 2022) Authors: Sofiyeva, Nigar; Krakstad, Camilla; Halle, Mari K.; O'Mara, Tracy A.; Romundstad, Pål; Hveem, Kristian; Vatten, Lars; Lønning, Per E.; Gansmo, Liv B.; Knappskog, Stian Journal: Cancer medicine Issue: Volume 12:Number 6(2023) Page Start: 6659 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Blocking 17β‐hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach. Issue 2 (3rd January 2018) Authors: Konings, Gonda FJ; Cornel, Karlijn MC; Xanthoulea, Sofia; Delvoux, Bert; Skowron, Margaretha A; Kooreman, Loes; Koskimies, Pasi; Krakstad, Camilla; Salvesen, Helga B; van Kuijk, Kim; Schrooders, Yannick JM; Vooijs, Marc; Groot, Arjan J; Bongers, Marlies Y; Kruitwagen, Roy FPM; Romano, Andrea Journal: Journal of pathology Issue: Volume 244:Issue 2(2018) Page Start: 203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗